Attached files
| file | filename |
|---|---|
| EX-31.2 - CERTIFICATION - AYTU BIOPHARMA, INC | f10q1217ex31-2_aytubiosci.htm |
| EX-31.1 - CERTIFICATION - AYTU BIOPHARMA, INC | f10q1217ex31-1_aytubiosci.htm |
| 10-Q - QUARTERLY REPORT - AYTU BIOPHARMA, INC | f10q1217_aytubioscience.htm |
Exhibit 32.1
AYTU BIOSCIENCE, INC.
Certification Pursuant to 18 U.S.C. Section 1350, as Adopted
Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002
In connection with the filing of the quarterly report on Form 10-Q for the quarter ended December 31, 2017 (the “Report”) by Aytu BioScience, Inc. (the “Company”), each of the undersigned hereby certifies that:
| 1. | The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended, and |
| 2. | The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company. |
| Dated: February 8, 2018 | /s/ Joshua R. Disbrow |
| Joshua R. Disbrow | |
| Chief Executive Officer | |
| Dated: February 8, 2018 | /s/ David A. Green |
| David A. Green | |
| Chief Financial Officer |